Kangmei Pharma | 600518 - Operating Expenses

Stock Price
1.71
Daily Change
-0.01 -0.58%
Monthly
-2.84%
Yearly
-11.86%
Q2 Forecast
1.69

Kangmei Pharma reported CNY1.39B in Operating Expenses for its fiscal quarter ending in September of 2025.





Operating Expenses Change Date
Akebia Therapeutics USD 63.08M 8.26M Dec/2025
Alaunos Therapeutics USD 1.19M 148K Sep/2025
Avita Medical AUD 28.02M 1.55M Dec/2025
Cspc Pharmaceutical CNY 5.91B 512.77M Dec/2025
Dianthus Therapeutics USD 69.82M 29.14M Dec/2025
Genomma Lab Internacional MXN 3.22B 257.3M Dec/2025
Hypermarcas BRL 1.59B 36.2M Dec/2025
Ionis Pharmaceuticals USD 418M 101.1M Dec/2025
IQVIA Holdings USD 1.69B 4.47B Dec/2025
Jiangsu Hengrui CNY 5.52B 604.29M Mar/2026
Kangmei Pharma CNY 1.39B 144.29M Sep/2025
Moderna USD 1.54B 259M Dec/2025
Organon & Co USD 906M 362M Sep/2025
Revvity USD 626.22M 25.62M Dec/2025
Sh Fosun Pharma CNY 11.3B 2.18B Dec/2025
Tectonic Therapeutic USD 21.52M 374K Dec/2025
Viatris USD 3.86B 335.7M Dec/2025
Wuxi Apptec CNY 7.84B 354.28M Dec/2025
Xeris Pharmaceuticals USD 69.03M 1.38M Dec/2025
Zz Pientze Pharmaceu CNY 1.55B 129.66M Sep/2025